Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Making sorafenib irresistible: In vivo screening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14.

× No keyword cloud information.

9 in total

1. Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.

Authors: Min Zheng; Huijuan Xu; Xin-Hua Liao; Champ Peng Chen; Arina Li Zhang; Wenxian Lu; Long Wang; Dayun Yang; Jichuang Wang; Hekun Liu; Xiao Zhen Zhou; Kun Ping Lu
Journal: Oncotarget Date: 2017-05-02

2. Sorafenib in adjuvant setting: call for precise and personalized therapy.

Authors: Wei Zhang
Journal: Transl Gastroenterol Hepatol Date: 2016-03-16

Review 3. Clinical implications of basic research in hepatocellular carcinoma.

Authors: Renumathy Dhanasekaran; Sudhakar K Venkatesh; Michael S Torbenson; Lewis R Roberts
Journal: J Hepatol Date: 2015-10-09 Impact factor: 25.083

4. Long noncoding RNA SNHG16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5p.

Authors: Junfeng Ye; Ruoyan Zhang; Xiaohong Du; Wengang Chai; Qiang Zhou
Journal: Onco Targets Ther Date: 2019-01-04 Impact factor: 4.147

5. RNA polymerase II subunit 3 regulates vesicular, overexpressed in cancer, prosurvival protein 1 expression to promote hepatocellular carcinoma.

Authors: Peng Hu; Binfeng Wang; Ting Chen; Yongfu Xu; Guoqun Zheng; Yu Zhu; Xuefeng Du
Journal: J Int Med Res Date: 2021-04 Impact factor: 1.671

9. FAM225A promotes sorafenib resistance in hepatocarcinoma cells through modulating miR-130a-5p-CCNG1 interaction network.

Authors: Yan Tong Liu; Guo Qing Liu; Jing Min Huang
Journal: Biosci Rep Date: 2020-11-27 Impact factor: 3.840

9 in total

Making sorafenib irresistible: In vivo screening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14.

1. Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.

2. Sorafenib in adjuvant setting: call for precise and personalized therapy.

Review 3. Clinical implications of basic research in hepatocellular carcinoma.

4. Long noncoding RNA SNHG16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5p.

5. RNA polymerase II subunit 3 regulates vesicular, overexpressed in cancer, prosurvival protein 1 expression to promote hepatocellular carcinoma.

6. LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinoma.

7. Tumor-Stroma Crosstalk Enhances REG3A Expressions that Drive the Progression of Hepatocellular Carcinoma.

8. HANR Enhances Autophagy-Associated Sorafenib Resistance Through miR-29b/ATG9A Axis in Hepatocellular Carcinoma.

9. FAM225A promotes sorafenib resistance in hepatocarcinoma cells through modulating miR-130a-5p-CCNG1 interaction network.